ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,554Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 199

$455K Total Retail Price of All Prescriptions

Rank: 72 out of 199

486 Patients Receiving at Least One Drug in Part D
91% Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nebraska
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

2% of this provider’s 486 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

9% of this provider’s 486 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$36 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 757 697 89 1 1
FUROSEMIDE 722 689 94 2 5
LISINOPRIL 349 344* 51 3 6
WARFARIN SODIUM 344 333 59 4 7
METOPROLOL SUCCINATE 269 252 44 5 11
OMEPRAZOLE 266 191 41 6 4
SIMVASTATIN 264 245 47 7 2
METOPROLOL TARTRATE 238 238 38 8 12
POTASSIUM CHLORIDE 219 191 30 9 10
HYDROCODONE-ACETAMINOPHEN 209 194 44 S3 10 9
AMLODIPINE BESYLATE 188 183* 30 11 3
GLIMEPIRIDE 179 145 32 12 38
PANTOPRAZOLE SODIUM 172 167* 22 13 25
NAMENDA 171 171 14 14 34
ALLOPURINOL 167 162* 21 15 22
GABAPENTIN 160 111 17 16 14
MONOJECT INSULIN SAFETY SYRNG 155 <11 <11 17 95
CIPROFLOXACIN HCL 152 147* 98 18 56
CARVEDILOL 147 127 19 19 21
METFORMIN HCL 141 111 19 20 13
HYDROCHLOROTHIAZIDE 140 135* 28 21 17
LOSARTAN POTASSIUM 134 118 22 22 15
ATORVASTATIN CALCIUM 128 128 19 23 8
RANITIDINE HCL 124 <11 <11 24 57
ATENOLOL 122 122 11 25 19
IBUPROFEN 121 116* 33 26 160
PREDNISONE 118 106 24 27 33
TEMAZEPAM 118 113* 21 B 27 116
LISINOPRIL-HYDROCHLOROTHIAZIDE 117 117 14 29 43
CEPHALEXIN 115 110* 84 30 104
CITALOPRAM HBR 115 102 16 30 20
SPIRONOLACTONE 113 <11 <11 32 39
ESCITALOPRAM OXALATE 108 97 12 33 36
TRAMADOL HCL 104 93 19 34 16
ALPRAZOLAM 102 97* 20 B 35 24
OXYBUTYNIN CHLORIDE ER 101 <11 <11 36 102
DIGOXIN 97 75 12 37 106
CLOPIDOGREL 93 67 11 38 27
PRAVASTATIN SODIUM 90 90 11 39 18
CLONIDINE HCL 79 79 13 40 52
LOSARTAN-HYDROCHLOROTHIAZIDE 78 73* 12 41 49
SULFAMETHOXAZOLE-TRIMETHOPRIM 78 66 44 41 93
TAMSULOSIN HCL 73 <11 <11 43 26
KLOR-CON M10 71 <11 <11 44 99
MELOXICAM 71 58 13 44 32
LORAZEPAM 70 65* 16 B 46 40
PAROXETINE HCL 70 <11 <11 46 73
LANSOPRAZOLE 66 <11 <11 48 175
ADVAIR DISKUS 65 65 16 49 51
VESICARE 64 <11 <11 50 67
FLUTICASONE PROPIONATE 63 58* 12 51 35
AMITRIPTYLINE HCL 63 63 11 R 51 75
AMLODIPINE BESYLATE-BENAZEPRIL 61 <11 <11 53 98
CELEBREX 60 55* 12 54 63
NIFEDIPINE ER 58 <11 <11 55 265
VENLAFAXINE HCL ER 57 <11 <11 56 76
ZOLPIDEM TARTRATE 57 52* 15 56 28
DONEPEZIL HCL 53 <11 <11 58 30
PROPRANOLOL HCL 52 <11 <11 59 94
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.